BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 35731212)

  • 1. TRAF4 Inhibits Bladder Cancer Progression by Promoting BMP/SMAD Signaling.
    Iyengar PV; Marvin DL; Lama D; Tan TZ; Suriyamurthy S; Xie F; van Dinther M; Mei H; Verma CS; Zhang L; Ritsma L; Ten Dijke P
    Mol Cancer Res; 2022 Oct; 20(10):1516-1531. PubMed ID: 35731212
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor necrosis factor-receptor-associated factor-4 is a positive regulator of transforming growth factor-beta signaling that affects neural crest formation.
    Kalkan T; Iwasaki Y; Park CY; Thomsen GH
    Mol Biol Cell; 2009 Jul; 20(14):3436-50. PubMed ID: 19458200
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ubiquitination of tumor necrosis factor receptor-associated factor 4 (TRAF4) by Smad ubiquitination regulatory factor 1 (Smurf1) regulates motility of breast epithelial and cancer cells.
    Wang X; Jin C; Tang Y; Tang LY; Zhang YE
    J Biol Chem; 2013 Jul; 288(30):21784-92. PubMed ID: 23760265
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TRAF4 promotes TGF-β receptor signaling and drives breast cancer metastasis.
    Zhang L; Zhou F; García de Vinuesa A; de Kruijf EM; Mesker WE; Hui L; Drabsch Y; Li Y; Bauer A; Rousseau A; Sheppard KA; Mickanin C; Kuppen PJ; Lu CX; Ten Dijke P
    Mol Cell; 2013 Sep; 51(5):559-72. PubMed ID: 23973329
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ubiquitin ligase Smurf1 targets TRAF family proteins for ubiquitination and degradation.
    Li S; Lu K; Wang J; An L; Yang G; Chen H; Cui Y; Yin X; Xie P; Xing G; He F; Zhang L
    Mol Cell Biochem; 2010 May; 338(1-2):11-7. PubMed ID: 19937093
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TRAF4 positively regulates the osteogenic differentiation of mesenchymal stem cells by acting as an E3 ubiquitin ligase to degrade Smurf2.
    Li J; Wang P; Xie Z; Wang S; Cen S; Li M; Liu W; Tang S; Ye G; Zheng G; Su H; Ma M; Wu X; Wu Y; Shen H
    Cell Death Differ; 2019 Dec; 26(12):2652-2666. PubMed ID: 31076633
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TRAF4 Promotes the Proliferation of Glioblastoma by Stabilizing SETDB1 to Activate the AKT Pathway.
    Gu H; Zhu S; Peng C; Wei Z; Shen Y; Yuan C; Yang H; Cui H; Yang L
    Int J Mol Sci; 2022 Sep; 23(17):. PubMed ID: 36077559
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Down-regulation of TRAF4 targeting RSK4 inhibits proliferation, invasion and metastasis in breast cancer xenografts.
    Zhu L; Zhang S; Huan X; Mei Y; Yang H
    Biochem Biophys Res Commun; 2018 Jun; 500(3):810-816. PubMed ID: 29684350
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ubiquitin ligase Smurf1 mediates tumor necrosis factor-induced systemic bone loss by promoting proteasomal degradation of bone morphogenetic signaling proteins.
    Guo R; Yamashita M; Zhang Q; Zhou Q; Chen D; Reynolds DG; Awad HA; Yanoso L; Zhao L; Schwarz EM; Zhang YE; Boyce BF; Xing L
    J Biol Chem; 2008 Aug; 283(34):23084-92. PubMed ID: 18567580
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Smad Ubiquitination Regulatory Factor 1 (Smurf1) Promotes Thyroid Cancer Cell Proliferation and Migration via Ubiquitin-Dependent Degradation of Kisspeptin-1.
    Yan C; Su H; Song X; Cao H; Kong L; Cui W
    Cell Physiol Biochem; 2018; 49(5):2047-2059. PubMed ID: 30244247
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TRAF4-mediated ubiquitination of NGF receptor TrkA regulates prostate cancer metastasis.
    Singh R; Karri D; Shen H; Shao J; Dasgupta S; Huang S; Edwards DP; Ittmann MM; O'Malley BW; Yi P
    J Clin Invest; 2018 Jul; 128(7):3129-3143. PubMed ID: 29715200
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TRAF4 Maintains Deubiquitination of Caveolin-1 to Drive Glioblastoma Stemness and Temozolomide Resistance.
    Li Y; Wang T; Wan Q; Wang Q; Chen Z; Gao Y; Ye Y; Lin J; Zhao B; Wang H; Yang J; Zhao K; Lu N
    Cancer Res; 2022 Oct; 82(19):3573-3587. PubMed ID: 35895752
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TRAF4 mediates activation of TGF-β signaling and is a biomarker for oncogenesis in breast cancer.
    Zhou F; Li F; Xie F; Zhang Z; Huang H; Zhang L
    Sci China Life Sci; 2014 Dec; 57(12):1172-6. PubMed ID: 25249198
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular interaction between Smurf1 WW2 domain and PPXY motifs of Smad1, Smad5, and Smad6--modeling and analysis.
    Sangadala S; Metpally RP; Reddy BV
    J Biomol Struct Dyn; 2007 Aug; 25(1):11-23. PubMed ID: 17676934
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stabilization of MCL-1 by E3 ligase TRAF4 confers radioresistance.
    Li M; Gao F; Li X; Gan Y; Han S; Yu X; Liu H; Li W
    Cell Death Dis; 2022 Dec; 13(12):1053. PubMed ID: 36535926
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SCFFBXL¹⁵ regulates BMP signalling by directing the degradation of HECT-type ubiquitin ligase Smurf1.
    Cui Y; He S; Xing C; Lu K; Wang J; Xing G; Meng A; Jia S; He F; Zhang L
    EMBO J; 2011 May; 30(13):2675-89. PubMed ID: 21572392
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LncRNA HCG18 upregulates TRAF4/TRAF5 to facilitate proliferation, migration and EMT of epithelial ovarian cancer by targeting miR-29a/b.
    Zhang F; Luo BH; Wu QH; Li QL; Yang KD
    Mol Med; 2022 Jan; 28(1):2. PubMed ID: 34983361
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TRAF4 enhances osteosarcoma cell proliferation and invasion by Akt signaling pathway.
    Yao W; Wang X; Cai Q; Gao S; Wang J; Zhang P
    Oncol Res; 2014; 22(1):21-28. PubMed ID: 25700355
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TRAF4 enhances oral squamous cell carcinoma cell growth, invasion and migration by Wnt-β-catenin signaling pathway.
    Yang J; Wei D; Wang W; Shen B; Xu S; Cao Y
    Int J Clin Exp Pathol; 2015; 8(9):11837-46. PubMed ID: 26617938
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TRAF4 hyperactivates HER2 signaling and contributes to Trastuzumab resistance in HER2-positive breast cancer.
    Gu Y; Gao H; Zhang H; John A; Zhu X; Shivaram S; Yu J; Weinshilboum RM; Wang L
    Oncogene; 2022 Aug; 41(35):4119-4129. PubMed ID: 35864174
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.